logo

For the Inventor, By the Inventor

San Diego, CA, United States of America

Antonio Garrido Montalban

LinkedIn
USPTO Granted Patents = 23 

 

 

Average Co-Inventor Count = 9.8

ph-index = 7

Forward Citations = 127(Granted Patents)


Company Filing History:

goldMedal20 out of 216 
 
Arena Pharmaceuticals, Inc.
 patents
silverMedal3 out of 3 
 
Itherx Pharmaceuticals Inc.
 patents

Years Active: 2010-2025

Loading Chart...
Loading Chart...
Loading Chart...
23 patents (USPTO):Explore Patents
1. 12378198 - Crystalline l-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(compound1) for use in SIPI receptor-associated disorders (2025-08-05),
2. 12109219 - Cannabinoid receptor modulators (2024-10-08),
3. 11884626 - Crystalline L-arginine salt of ()-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(Compound1) for use in S1Preceptor-associated disorders (2024-01-30),
4. 11771695 - Cannabinoid receptor modulators (2023-10-03),
5. 11674163 - Processes for the preparation of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts thereof (2023-06-13),
6. 11560369 - Crystalline forms and processes for the preparation of cannabinoid receptor modulators (2023-01-24),
7. 11149292 - Processes for the preparation of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[B]indol-3-yl)acetic acid and salts thereof (2021-10-19),
8. 11091435 - Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3, 4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(compound1) for use in S1Preceptor-associated disorders (2021-08-17),
9. 10981895 - Crystalline forms and processes for the preparation of cannabinoid receptor modulators (2021-04-20),
10. 10676435 - Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(Compound 1) for use in SIPI receptor-associated disorders (2020-06-09),
11. 10632134 - Cannabinoid receptor modulators (2020-04-28),
12. 10301262 - Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(Compund1) for use in SIPI receptor-associated disorders (2019-05-28),
13. 10183930 - Crystalline forms and processes for the preparation of cannabinoid receptor modulators (2019-01-22),
14. 9867822 - Cannabinoid receptor modulators (2018-01-16),
15. 9597340 - Cannabinoid receptor modulators (2017-03-21),

Title: The Innovative Mind of Antonio Garrido Montalban

Introduction: Antonio Garrido Montalban is a visionary inventor based in San Diego, CA, known for his groundbreaking contributions to various fields.

Latest Patents: Antonio Garrido Montalban holds several patents in the areas of renewable energy technologies, medical devices, and sustainable materials.

Career Highlights: With a career spanning over two decades, Antonio Garrido Montalban has worked tirelessly to bring his innovative ideas to life. He has been recognized for his exceptional problem-solving skills and creative approach to invention.

Collaborations: Throughout his career, Antonio Garrido Montalban has collaborated with leading research institutions, universities, and companies to further develop and commercialize his inventions. His collaborative spirit has led to successful partnerships and groundbreaking innovations.

Conclusion: Antonio Garrido Montalban continues to push the boundaries of innovation, inspiring others in the field with his creativity and passion for creating a better future through his inventions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…